Regeneron wins FDA approval for first gene therapy for genetic hearing loss - Reuters

Chronological Source Flow
Back

AI Fusion Summary

Regeneron received FDA approval for its first gene therapy targeting genetic hearing loss, marking a significant milestone in treating inherited auditory disorders. The approval follows successful clinical trials demonstrating safety and efficacy.
#REGENERON #FDA #GENETIC_HEARING_LOSS #GENE_THERAPY #US_REGULATION
23/04 20:34 google.com
3 Πηγές

Regeneron wins FDA approval for first gene therapy for genetic hearing loss - Reuters

POLITICS
23/04 23:46 npr.org

The FDA gives the green light to the first gene therapy for deafness

POLITICS
23/04 23:47 nbcnews.com

FDA approves first gene therapy for genetic hearing loss

Comments
Loading...
0